Shalanda Smith, | |
506 N Main St, Nicholasville, KY 40356-1134 | |
(833) 510-4357 | |
(866) 460-2997 |
Full Name | Shalanda Smith |
---|---|
Gender | Female |
Speciality | Licensed Vocational Nurse |
Location | 506 N Main St, Nicholasville, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679213250 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164X00000X | Licensed Vocational Nurse | 2031515 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Shalanda Smith, 615 Elsinore Pl, Cincinnati, OH 45202-1459 Ph: (833) 510-4357 | Shalanda Smith, 506 N Main St, Nicholasville, KY 40356-1134 Ph: (833) 510-4357 |
News Archive
NeoStem, Inc., an international biopharmaceutical company with a focus on cell-based therapeutic development, today announced that the Company was featured on CBS's Eye on New York City on Wednesday evening, August 24, 2011.
The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).
In a trial of 426 patients with Type 2 diabetes, TAK-875 reduced blood sugar below a pre-determined level in as much as 48 percent of those receiving it after 12 weeks, compared with 40 percent of those who took glimepiride, the older drug, according to findings published online by The Lancet medical journal. The research was presented in June at the American Diabetes Association's annual meeting in San Diego.
Kaplan EduNeering, a leading provider of compliance and knowledge management solutions, announces today the opening of a Hong Kong office to serve clients based in Asia. The new location, which will house sales and support staff, is based in the Hong Kong offices of its parent company, Kaplan, Inc. In 2008, Kaplan EduNeering opened a European-based location in Reading, England.
Australia is dedicating more government funding towards the establishment of a vibrant clinical trial ecosystem in order to accelerate the design, development, verification and product launch processes of medical devices, says GlobalData, a leading data and analytics company.
› Verified 5 days ago